Tianqiang Song
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 07, 2026
Perioperative tislelizumab plus lenvatinib treatment for resectable hepatocellular carcinoma at high risk of recurrence: single-arm phase II trial.Lu Chen, Shujie Zhai, Yayue Liu
|Nov 28, 2025
Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5.Lu Chen, Zhiqiang Han, Xiangdong Tian
|Oct 03, 2024
Benefit of Conversion Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Propensity Score-Matched Study.Ruyu Han, Leijuan Gan, Liyu Sun
|Jan 17, 2024
A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy.Ruyu Han, Leijuan Gan, Mengran Lang
|May 01, 2023
A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma.Leijuan Gan, Mengran Lang, Xindi Tian
|Aug 22, 2022
Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study.Leijuan Gan, Shaohua Ren, Mengran Lang
Pageof 1
